Literature DB >> 8045569

A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors.

G Belge1, B Thode, V Rippe, S Bartnitzke, J Bullerdiek.   

Abstract

The cytogenetic results from a series of 113 thyroid hyperplasias and adenomas are reported; 15 showed clonal karyotypic alterations. In addition to a group showing translocations involving 19q13, another subset of lesions characterized by polysomies can be found. Based on our own cases belonging to this subset and a review of the cases reported in the literature, we conclude that the characteristic feature of this group is a sequence that always starts with trisomy 7, but that sometimes even leads to chromosome numbers in the hypertriploid range. This subset of thyroid tumors may be an example of a more common genetic pathway in human solid tumors.

Entities:  

Mesh:

Year:  1994        PMID: 8045569     DOI: 10.1007/bf00202871

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Translocation t(5;19): a recurrent change in thyroid follicular adenoma.

Authors:  L Roque; S Castedo; A Clode; J Soares
Journal:  Genes Chromosomes Cancer       Date:  1992-06       Impact factor: 5.006

2.  Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas?

Authors:  G Belge; B Thode; J Bullerdiek; S Bartnitzke
Journal:  Cancer Genet Cytogenet       Date:  1992-05

3.  Cytogenetic biclonality corresponding to multiphasic differentiation in an atypical thyroid adenoma.

Authors:  G Belge; B Thode; S Bartnitzke; J Bullerdiek
Journal:  Cancer Genet Cytogenet       Date:  1994-11

4.  Frequent clonal chromosomal changes in human non-malignant tumors.

Authors:  J R Teyssier; D Ferre
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

Review 5.  Trisomy 7 in nonneoplastic cells.

Authors:  B Johansson; S Heim; N Mandahl; F Mertens; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1993-04       Impact factor: 5.006

6.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

7.  Cytogenetics of thyroid follicular adenomas.

Authors:  E van den Berg; J W Oosterhuis; B de Jong; J Buist; A Vos; A Dam; B Vermeij
Journal:  Cancer Genet Cytogenet       Date:  1990-02

8.  Trisomy 8 as a recurrent clonal abnormality in breast cancer?

Authors:  J Bullerdiek; E Leuschner; E Taquia; U Bonk; S Bartnitzke
Journal:  Cancer Genet Cytogenet       Date:  1993-01

9.  Cytogenetic analysis of a multinodular thyroid goiter.

Authors:  N B Gama; R Gama; J A Thomé; E H Tajara
Journal:  Cancer Genet Cytogenet       Date:  1991-08

10.  Ploidy level and proliferative activity measurements in a series of 407 thyroid tumors or other pathologic conditions.

Authors:  I Salmon; P Gasperin; M Remmelink; I Rahier; P Rocmans; J L Pasteels; R Heimann; R Kiss
Journal:  Hum Pathol       Date:  1993-08       Impact factor: 3.466

View more
  4 in total

Review 1.  Review of allelic loss and gain in prostate cancer.

Authors:  G S Bova; W B Isaacs
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

2.  Allelotyping of follicular thyroid tumors.

Authors:  J Zedenius; G Wallin; A Svensson; L Grimelius; A Höög; G Lundell; M Bäckdahl; C Larsson
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

3.  Interphase cytogenetics of prostate cancer: fluorescence in situ hybridisation (FISH) analysis of Japanese cases.

Authors:  H Matsuura; T Shiraishi; R Yatani; J Kawamura
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

Authors:  S Hemmer; V M Wasenius; S Knuutila; H Joensuu; K Franssila
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.